HL
Hanumant Laxman Dalvi
About Hanumant Laxman Dalvi
Data last updated:
Hanumant Laxman Dalvi is a Director at Neilsen Biological Private Limited (since 2021) and Director at Neilsen Surgical Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Neilsen Biological Private Limited at ₹1.83 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Mar 2021 | 2021 | ₹1.83 Cr (FY 2024) | Active | |
| Director | 16 Dec 2025 | 2025 | Active |
Board colleagues of Hanumant Laxman Dalvi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Puja Pranav Sawale | 07993008 | Neilsen Biological Private Limited , Neilsen Surgical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hanumant Laxman Dalvi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hanumant Laxman Dalvi
Hanumant Laxman Dalvi currently holds 2 directorships: Neilsen Biological Private Limited (Director, since 25 Mar 2021, revenue ₹1.83 Cr (FY 2024)); Neilsen Surgical Private Limited (Director, since 16 Dec 2025).
Hanumant Laxman Dalvi was first appointed on 25 Mar 2021 as Director at Neilsen Biological Private Limited. The most recent appointment on record is 16 Dec 2025 at Neilsen Surgical Private Limited.
The current boards of Hanumant Laxman Dalvi's companies include Puja Pranav Sawale (Neilsen Biological Private Limited).